TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia.

Noelle V Frey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.